Annexon, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANNX research report →
About the company
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway.
- CEO
- Douglas E. Love
- IPO
- 2020
- Employees
- 106
- HQ
- Brisbane, CA, US
Price Chart
- Market Cap
- $652.99M
- P/E
- -5.40
- P/S
- 0.00
- P/B
- 5.18
- EV/EBITDA
- -2.60
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -101.19%
- ROIC
- -89.17%
- Revenue
- $0 · 0.00%
- Net Income
- $-206,690,000 · -49.56%
- EPS
- $-1.34 · -32.67%
- Op Income
- $-216,407,000
- FCF YoY
- -58.02%
- 52W High
- $7.18
- 52W Low
- $1.85
- 50D MA
- $5.39
- 200D MA
- $4.87
- Beta
- 1.17
- Avg Volume
- 2.94M
Get TickerSpark's AI analysis on ANNX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Waddill William D. | other | 65,000 |
| Jun 11, 26 | Satter Muneer A | other | 65,000 |
| Jun 11, 26 | JONES WILLIAM A JR | other | 65,000 |
| Jun 11, 26 | Cockroft Bettina M. | other | 65,000 |
| Jun 11, 26 | Choi Jung | other | 65,000 |
| Jun 11, 26 | Carson William H. | other | 65,000 |
| Jun 11, 26 | Yednock Ted | other | 30,646 |
| Jun 11, 26 | Yednock Ted | other | 30,646 |
| May 28, 26 | Satter Muneer A | buy | 613,497 |
| May 11, 26 | Carson William H. | buy | 8,000 |
Our ANNX coverage
Recent articles, reports, and earnings notes.
No research on ANNX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANNX report →Similar companies
Peers in the same neighborhood.